Mission-driven derisking MBI is a mission-inspired, not-for-profit biotech accelerator known for rapid, milestone-based derisking of biobased fuels, chemicals, and materials, presenting a strong selling point to partners seeking cost-efficient project de-risking and accelerated time-to-market.

Industrial collaborations With a robust network of partners including Bolt Threads, Verdezyne, DuPont, Genomatica, Novozymes, NatureWorks, and the Great Lakes Bioenergy Research Center, MBI offers access to proven industry relationships and potential co-development opportunities for sponsors looking to validate technologies at scale.

Scale-ready capabilities MBI provides an integrated pathway from lab to bench and pilot scales, combining science, engineering, operations, and business expertise, enabling buyers to move candidates quickly through validation stages and into commercialization.

Strategic MSU affiliation As a wholly owned subsidiary of the MSU Foundation with MSU affiliation, MBI can leverage university-backed credibility, resources, and potential grant or collaboration funding, appealing to both corporate and academic partners seeking risk-sharing opportunities.

Sustainable tech focus MBI’s emphasis on renewable biobased fuels, chemicals, and materials aligns with sustainability-focused buyers and public incentives, making it a compelling partner for teams seeking environmentally beneficial, scalable biotechnologies.